Continuous Renal Replacement Therapy Combined with Hemoadsorption in the Treatment of Severe Systemic Lupus Erythematosus Flare Complicated by Acute Kidney Injury and Severe Gastrointestinal Bleeding: A Case Report

Pham Khac Tiep, Tran Ba Dung, Nguyen Van Thang, Dau Viet Hung

Main Article Content

Abstract

We report a case of a 14-year-old female with active Systemic Lupus Erythematosus complicated by acute kidney injury with anuria and diffuse gastrointestinal bleeding, who was treated with continuous renal replacement therapy combined with hemoadsorption. Inflammatory markers, renal function, and hematological parameters were monitored before treatment and at 24, 48, and 72 hours. The patient demonstrated a marked decline in IL-6 levels from 612 to 68.1 pg/mL over 72 hours, while procalcitonin (PCT) decreased rapidly within the first 48 hours. Serum urea and creatinine levels progressively declined, platelet counts gradually recovered, gastrointestinal bleeding was effectively controlled, urine output resumed from day 7, and continuous renal replacement therapy was subsequently discontinued. However, given the concomitant use of multiple therapies, including high-dose corticosteroids, broad-spectrum antibiotics, blood transfusions, and intensive supportive care, a causal relationship between individual interventions and clinical improvement could not be established. Nevertheless, this case suggests that the combination of continuous renal replacement therapy and hemoadsorption may represent a potential adjunctive therapeutic strategy in severe lupus with acute kidney injury and gastrointestinal bleeding.

Article Details

References

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011; 365(22): 2110-2121. doi:10.1056/NEJMra1100359.
2. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014; 6(10): a016295. Published 2014 Sep 4. doi:10.1101/cshperspect.a016295.
3. Tian XP, Zhang X. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol. 2010; 16(24): 2971-2977. doi:10.3748/wjg.v16.i24.2971.
4. Section 5: Dialysis Interventions for Treatment of AKI. Kidney International Supplements 2012 Vol. 2 Issue 1 Pages 89-115. DOI: 10.1038/kisup.2011.35.
5. Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher. 2023; 38(2): 77-278. doi:10.1002/jca.22043.
6. Ronco C, Bagshaw SM, Bellomo R, et al. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation. Blood Purif. 2021; 50(1): 17-27. doi:10.1159/000508125.
7. Heymann M, Schorer R, Putzu A. The Effect of CytoSorb on Inflammatory Markers in Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Med. 2023; 51(12): 1659-1673. doi:10.1097/CCM.0000000000006007.
8. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019; 78(9): 1151-1159. doi:10.1136/annrheumdis-2018-214819.
9. Schlapbach LJ, Watson RS, Sorce LR, et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024; 331(8): 665-674. doi:10.1001/jama.2024.0179.
10. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48(2): 124-131. doi:10.1002/pbc.21039.
11. Ankawi G, Xie Y, Yang B, Ronco C. What Have We Learned about the Use of Cytosorb Adsorption Columns? Blood Purif. 2019; 48(3): 196-202. doi:10.1159/000500013.
12. Friesecke S, Stecher SS, Gross S, Felix SB, Nierhaus A. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017; 20(3): 252-259. doi:10.1007/s10047-017-0967-4.
13. Kronbichler A, Brezina B, Quintana LF, Jayne DR. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review. Autoimmun Rev. 2016; 15(1): 38-49. doi:10.1016/j.autrev.2015.08.010.
14. Stummvoll GH, Schmaldienst S, Smolen JS, Derfler K, Biesenbach P. Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity. Nephrol Dial Transplant. 2012; 27(2): 618-626. doi:10.1093/ndt/gfr239.